2024
Beneficial and Detrimental Effects of Cytokines during Influenza and COVID-19
Chang D, Dela Cruz C, Sharma L. Beneficial and Detrimental Effects of Cytokines during Influenza and COVID-19. Viruses 2024, 16: 308. PMID: 38400083, PMCID: PMC10892676, DOI: 10.3390/v16020308.Peer-Reviewed Original ResearchConceptsDetrimental effects of cytokinesEffects of cytokinesSignaling moleculesUnfavorable outcomeMyriad processesPathological functionsCytokine effectsInflammatory cytokinesAntiviral cytokinesCytokinesViral infectionDisease severityPathological consequencesHomeostatic functionsOrganism deathDisease
2023
The emergence of influenza B as a major respiratory pathogen in the absence of COVID-19 during the 2021–2022 flu season in China
Chang D, Lin M, Song N, Zhu Z, Gao J, Li S, Liu H, Liu D, Zhang Y, Sun W, Zhou X, Yang B, Li Y, Wang L, Xiao Z, Li K, Xing L, Xie L, Sharma L. The emergence of influenza B as a major respiratory pathogen in the absence of COVID-19 during the 2021–2022 flu season in China. Virology Journal 2023, 20: 189. PMID: 37620959, PMCID: PMC10463403, DOI: 10.1186/s12985-023-02115-x.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedChinaCOVID-19COVID-19 TestingHumansInfluenza, HumanMiddle AgedSeasonsYoung AdultConceptsInfluenza BAverage ageCOVID-19Influenza-like illnessNumber of patientsMajor respiratory pathogenCOVID-19 testCOVID-19-related restrictionsCell death markersClinical characteristicsFever clinicYounger patientsAppropriate vaccinationPatient characteristicsSubstantial morbidityRespiratory virusesSeasonal virusesLaboratory findingsPositivity rateInfluenza ARespiratory pathogensPreventive strategiesSecondary infectionSevere casesFlu season
2019
When “B” becomes “A”: the emerging threat of influenza B virus
Sharma L, Rebaza A, Dela Cruz CS. When “B” becomes “A”: the emerging threat of influenza B virus. European Respiratory Journal 2019, 54: 1901325. PMID: 31416813, DOI: 10.1183/13993003.01325-2019.Commentaries, Editorials and LettersConceptsInfluenza B virusInfluenza BB virusHigh mortality rateInfluenza AMortality rateEnteric Virus Surveillance SystemInfluenza virusInfluenza B infectionVirus Surveillance SystemAvailability of vaccinesSevere lung infectionYears of ageStrains of influenzaVictoria-like strainsHuman respiratory tractLethal infectious diseaseNational RespiratoryB infectionHIV patientsPediatric populationLung infectionRespiratory tractSevere diseaseWorse disease
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply